These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8912872)

  • 41. HPV E1 up-regulates replication-related biochemistries of AAV Rep78.
    Bandyopadhyay S; Cao M; Liu Y; Hermonat PL
    Virology; 2010 Jun; 402(1):94-101. PubMed ID: 20378143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of the terminal repeat GAGC trimer, the major Rep78 binding site, in adeno-associated virus DNA replication.
    Bishop BM; Santin AD; Quirk JG; Hermonat PL
    FEBS Lett; 1996 Nov; 397(1):97-100. PubMed ID: 8941722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adeno-associated virus Rep78 restricts adenovirus E1B55K-mediated p53 nuclear exportation.
    Wang J; Li W; Wang R; Xue J; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2013 Feb; 45(2):135-40. PubMed ID: 23165746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissociation of conventional DNA binding and endonuclease activities by an adeno-associated virus Rep78 mutant.
    Batchu RB; Hermonat PL
    Biochem Biophys Res Commun; 1995 May; 210(3):717-25. PubMed ID: 7763245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter.
    Greger IH; Demarchi F; Giacca M; Proudfoot NJ
    Nucleic Acids Res; 1998 Mar; 26(5):1294-301. PubMed ID: 9469840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Promoter for the human ferritin heavy chain-encoding gene (FERH): structural and functional characterization.
    Bevilacqua MA; Giordano M; D'Agostino P; Santoro C; Cimino F; Costanzo F
    Gene; 1992 Feb; 111(2):255-60. PubMed ID: 1541403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53 regulates Ki-67 promoter activity through p53- and Sp1-dependent manner in HeLa cells.
    Wang MJ; Pei DS; Qian GW; Yin XX; Cheng Q; Li LT; Li HZ; Zheng JN
    Tumour Biol; 2011 Oct; 32(5):905-12. PubMed ID: 21611785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Down-regulation of the human c-fos and c-myc proto-oncogene promoters by adeno-associated virus Rep78.
    Hermonat PL
    Cancer Lett; 1994 Jun; 81(2):129-36. PubMed ID: 8012930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of the transcription factor Sp1 with the nuclear pore protein p62 requires the C-terminal domain of p62.
    Han I; Roos MD; Kudlow JE
    J Cell Biochem; 1998 Jan; 68(1):50-61. PubMed ID: 9407313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral Proteins as Emerging Cancer Therapeutics.
    Manocha E; Caruso A; Caccuri F
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34063663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The function of DNA binding protein nucleophosmin in AAV replication.
    Satkunanathan S; Thorpe R; Zhao Y
    Virology; 2017 Oct; 510():46-54. PubMed ID: 28704696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adeno-associated virus Rep represses the human integration site promoter by two pathways that are similar to those required for the regulation of the viral p5 promoter.
    Dutheil N; Smith SC; Agúndez L; Vincent-Mistiaen ZI; Escalante CR; Linden RM; Henckaerts E
    J Virol; 2014 Aug; 88(15):8227-41. PubMed ID: 24829354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of cellular proteins that interact with the adeno-associated virus rep protein.
    Nash K; Chen W; Salganik M; Muzyczka N
    J Virol; 2009 Jan; 83(1):454-69. PubMed ID: 18971280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preferential integration of adeno-associated virus type 2 into a polypyrimidine/polypurine-rich region within AAVS1.
    McAlister VJ; Owens RA
    J Virol; 2007 Sep; 81(18):9718-26. PubMed ID: 17626070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions.
    Bevington JM; Needham PG; Verrill KC; Collaco RF; Basrur V; Trempe JP
    Virology; 2007 Jan; 357(1):102-13. PubMed ID: 16959286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adeno-associated virus rep protein-mediated inhibition of transcription of the adenovirus major late promoter in vitro.
    Needham PG; Casper JM; Kalman-Maltese V; Verrill K; Dignam JD; Trempe JP
    J Virol; 2006 Jul; 80(13):6207-17. PubMed ID: 16775308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure of adeno-associated virus type 2 Rep40-ADP complex: insight into nucleotide recognition and catalysis by superfamily 3 helicases.
    James JA; Aggarwal AK; Linden RM; Escalante CR
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12455-60. PubMed ID: 15310852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reannotation of the CELO genome characterizes a set of previously unassigned open reading frames and points to novel modes of host interaction in avian adenoviruses.
    Washietl S; Eisenhaber F
    BMC Bioinformatics; 2003 Nov; 4():55. PubMed ID: 14604445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies of the mechanism of transactivation of the adeno-associated virus p19 promoter by Rep protein.
    Lackner DF; Muzyczka N
    J Virol; 2002 Aug; 76(16):8225-35. PubMed ID: 12134028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adeno-associated virus type 2 Rep78 inhibition of PKA and PRKX: fine mapping and analysis of mechanism.
    Schmidt M; Chiorini JA; Afione S; Kotin R
    J Virol; 2002 Feb; 76(3):1033-42. PubMed ID: 11773379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.